COMP <GO>
FTRE vs CLOV // DIVIDEND YIELD & FCF PAYOUT SAFETY
Fortrea Holdings Inc. (NASDAQ) VS. Clover Health Investments Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: FTRE 2
— CLOV 6
■ METRIC PARITY
LAST: $23.14 (-10.61%) • MKT CAP: $2.20B
dividend-safety
0.00%
LAST: $4.58 (-4.38%) • MKT CAP: $2.43B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTRE VS. CLOV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FTRE | CLOV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -29.30% | -5.70 | CLOV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.41% | -2.84% | +2.43 | FTRE | /fcf-yield <GO> |
| Operating Margin | -32.00% | -4.40% | -27.60 | CLOV | /operating-margins <GO> |
| Net Profit Margin | -36.30% | -4.40% | -31.90 | CLOV | /net-margins <GO> |
| Revenue Growth (YoY) | 1.00% | 40.30% | -39.30 | CLOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 3.62 | -3.17 | CLOV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.9 | 49.5 | +5.40 | FTRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.20B | $2.43B | -$232.6M | CLOV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FTRE REV | CLOV REV | FTRE GROSS % | CLOV GROSS % | FTRE FCF | CLOV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $1.92B | — | — | -$9.1M | -$69.0M |
| FY 2024 | $2.70B | $1.37B | — | — | $141.5M | $33.3M |
| FY 2023 | $2.84B | $1.26B | — | — | $40.5M | -$144.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTRE // BETA 0.99
CLOV // BETA —